HLA-A and cancer: To confirm the presentation of PRAME-derived peptides by HLA class I molecules, immunopeptidomic analyses were performed on a large set of HLA-A*02:01+ immortalized cell lines (data not shown) and tissue specimens of multiple cancer types.